Clinical TrialID 390
Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors
NCT00014378
Unspecified Adult Solid Tumor, Protocol Specific
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 390
- Evidence Id
- 390
- Core Evidence Id
- 390
- Source Clinical Trial Id
- 376
- Herb2 Clinical Trial Id
- HBCT000376
- Nct Id
- NCT00014378
- Title
- Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors
- Status
- Completed
- Phase
- Phase 1
- Study Result
- No
- Study Condition
- Unspecified Adult Solid Tumor, Protocol Specific
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: Chinese Herb Huanglian (Coptis chinesis)
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 34
- Outcome Measure
- Sponsor Collaborator
- Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI)
- Funded By
- OTHER
- Location
- Memorial Sloan-Kettering Cancer Center, New York, New York, 10021, United States
- Other Id
- 00-061|MSKCC-00061|NCI-H01-0069
- Start Date
- 2000-10
- Primary Completion Date
- 2007-12
- Completion Date
- 2007-12
- First Posted
- 2003-01-27
- Results First Posted
- Last Update Posted
- 2015-12-18
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00014378
- Title Cn
- Title En
- Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors
- Bilingual Status
- semi_complete